563
Participants
Start Date
September 27, 2018
Primary Completion Date
October 11, 2019
Study Completion Date
October 11, 2019
No treatment given
The participants will undergo a brief physical examination focused on neurologic function (muscle function, sensation, coordination, walking). Parents will be asked by the study team or the psychologist about their children and will complete several commonly used standard surveys about brain development, thinking, behavior, and decision making. The participants will also engage with the psychologist to evaluate development or thinking (IQ), and depending on their age they may be asked to complete one or more commonly used standard surveys about behavior and decision making.
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Charlotte
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Tampa
Novo Nordisk Investigational Site, Nashville
Novo Nordisk Investigational Site, Cleveland
Novo Nordisk Investigational Site, Indianapolis
Novo Nordisk Investigational Site, Ann Arbor
Novo Nordisk Investigational Site, Detroit
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Chicago
Novo Nordisk Investigational Site, New Orleans
Novo Nordisk Investigational Site, Oklahoma City
Novo Nordisk Investigational Site, Aurora
Novo Nordisk Investigational Site, Salt Lake City
Novo Nordisk Investigational Site, Los Angeles
Novo Nordisk Investigational Site, San Diego
Novo Nordisk Investigational Site, Orange
Novo Nordisk Investigational Site, Seattle
Novo Nordisk Investigational Site, Washington D.C.
Novo Nordisk Investigational Site, Boston
Novo Nordisk Investigational Site, Omaha
Lead Sponsor
Novo Nordisk A/S
INDUSTRY